Prostate Cancer - Results from #19900

Functional MRI in prostate cancer detection - Abstract October 30, 2014

Clinical (non-histological) diagnosis of advanced prostate cancer: Evaluation of treatment outcome after androgen deprivation therapy - Abstract October 30, 2014

Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery - Abstract October 30, 2014

Hypofractionated IMRT of the prostate bed after radical prostatectomy: Acute toxicity in the PRIAMOS-1 trial - Abstract October 30, 2014

Oncologic results, functional outcomes, and complication rates of robotic-assisted radical prostatectomy: Multicenter experience in Turkey including 1,499 patients - Abstract October 30, 2014

Most Internet sources on prostate cancer disagree with expert panel's recommendation October 30, 2014

Application of bone scans for prostate cancer staging: Which guideline shows better result? - Abstract October 29, 2014

Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer - Abstract October 29, 2014

Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery - Abstract October 29, 2014

Long-term outcomes from dose-escalated image-guided intensity-modulated radiotherapy with androgen deprivation: Encouraging results for intermediate- and high-risk prostate cancer - Abstract October 29, 2014

Primary circulating prostate cells are not detected in men with low grade small volume prostate cancer - Abstract October 29, 2014

Long-term complications in men who have early or late radiotherapy after radical prostatectomy - Abstract October 29, 2014

Quality of care indicators and their related outcomes: A population-based study in prostate cancer patients treated with radical prostatectomy - Abstract October 29, 2014

A comparative analysis of complications after robot-assisted radical prostatectomy for men aged ≤69 and ≥70 years - Abstract October 29, 2014

Coupling of prostate and thyroid cancer diagnoses in the United States - Abstract October 29, 2014

Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations - Abstract October 28, 2014

Tolerance of Phellodendron amurense bark extract (Nexrutine®) in patients with human prostate cancer - Abstract October 28, 2014

Three-dimensional dose prediction based on two-dimensional verification measurements for IMRT - Abstract October 28, 2014

Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: Changing focus from rectal bleeding to detailed quality of life analysis - Abstract October 28, 2014

Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer - Abstract October 28, 2014

Page 996 of 1458